4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-26-416950
Director sold 30,000 shares at $27.70 ($830,904)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| MILNE GEORGE M JR Director | 2026-10-05 | Sale 10b5-1 | −30,000 | $27.70 | $830,904 | 782,881 | D: show line 1 in the form |
| Open-market sales · 30,000 sh · avg $27.70 · $830,904 | |||||||
Loading xslF345X06/ownership.xml…